Top news of the week: 18.02.2021.
Career And Jobs
University of Oregon Campus Could Be Cornerstone of New Biotech Hotspot
A new biotech hotspot could be on the horizon in Oregon thanks to a $500 million gift to the University of Oregon from Nike co-founder Phil Knight, an alumnus of the university.
AI Generates Unprecedented Diversity of AAV Capsids
AI advances gene therapies by generating the functional diversity needed for AAVs to evade neutralization by the immune system.
C.D.C. Announces $200 Million ‘Down Payment’ to Track Virus Variants
Scientists say the new investment will help in the next couple of months, but hope that the stimulus package will provide much more.
Coronavirus Vaccine Nears Final Tests in Cuba. Tourists May Be Inoculated.
Amid bread shortages, Cuba gets one step closer to a scientific milestone: the mass production of a coronavirus vaccine invented on the island.
On Streamlining Kick, GSK Divests Antibiotics Business to Sandoz for $500 Million
Under the terms of the deal, Sandoz is paying GSK $350 million at closing and additional milestones up to $150 million.
Eyeing variants, Adagio starts phase 1 trial of COVID-19 antibody
Adagio Therapeutics has dosed the first subject with its anti-SARS-CoV-2 antibody. Administration of the candidate, which Adagio expects to be effective against coronavirus variants, ...
GlaxoSmithKline doubles down on Vir pact, throwing in $345M upfront to go beyond COVID-19
Last year, Big Pharma GlaxoSmithKline and George Scangos’ biotech Vir joined forces against COVID-19. Now, the pair is turning its crosshairs on a broader range of respiratory diseases.
The top 10 biotech IPOs of 2020
The class of 2020 biotech IPOs will go down as one of the most buoyant in history, with the leading 10 raising a massive $3.19 billion collectively.